Sunrun downgraded at Jefferies with more market uncertainty to come
Sunrun (NASDAQ:RUN) -4.3% in Wednesday's trading as Jefferies downgrades to Hold from Buy with an $8 price target, slashed ...
PepsiCo is rated a notch below Coca-Cola, Keurig Dr Pepper, and Monster Beverage by Jefferies
Jefferies lowered its rating on PepsiCo (NASDAQ:PEP) on Wednesday after the food and beverage stock had recently gained amid ...
Jefferies: A Bargain As Fundamentals Improve
Discover why Jefferies Financial Group is a strong buy at ~$55, with improving efficiency, diverse revenue streams, and ...
Green Plains plunges to multiyear low; Jefferies cuts as ethanol headwinds seen persisting
Green Plains downgraded at Jefferies, seeing ethanol margins likely remaining negative for longer on lower ethanol and higher ...
Market correction likely over as fundamentals turn favorable: Jefferies’ Mahesh Nandurkar
With the Reserve Bank of India now focusing on improving liquidity, Nandurkar believes the worst of the slowdown is over.
Jefferies Sticks to Their Buy Rating for Jungheinrich (0EXP)
In a report released today, Lucas Ferhani from Jefferies maintained a Buy rating on Jungheinrich (0EXP – Research Report), with a price target ...
Jefferies Starts Coverage on Coherent (COHR) with a Buy Rating
We recently published a list of Top 10 Stocks on Analysts’ Radar These Days. In this article, we are going to take a look at ...
Jefferies Keeps Their Buy Rating on Synchrony Financial (SYF)
In a report released today, John Hecht from Jefferies maintained a Buy rating on Synchrony Financial (SYF – Research Report), with a price ...
Banks offer best risk-reward, IT stocks still expensive: Jefferies’ Mahesh Nandurkar
Given the broader market’s correction, with over 100 stocks trading below their long-term averages, Mahesh sees little reason ...
Down 35% in 2025 YTD, Jefferies initiates coverage on Swiggy with ’Hold’ rating, sees 13% upside
Jefferies has assigned a ’hold’ rating to Swiggy, setting a price target of ₹400 amid a 35% stock decline in 2025. Despite ...
NovoNordisk stock falls on Roche-Zealand pact; Jefferies cuts target
Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand Pharma A/S (CSE:ZELA).